Comprehensive Care Management

Comprehensive Management of Diabetes and Chronic Kidney Disease: A Strategic Approach Managing patients with diabetes and chronic kidney disease (CKD) requires a structured, multidisciplinary approach to slow disease progression, reduce cardiovascular risks, and optimize overall health. This framework outlines an evidence-based strategy for achieving these goals. 1️⃣ Lifestyle Modifications: The Foundation Before initiating pharmacotherapy, lifestyle interventions play a critical role: ✅ Healthy diet ✅ Physical activity ✅ Smoking cessation ✅ Weight management Regular reassessment of risk factors every 3-6 months is essential to adjust treatment accordingly. 2️⃣ Pharmacotherapy: Individualized & Evidence-Based 🔹 Metformin: First-line therapy for type 2 diabetes, initiated if eGFR ≥30 mL/min/1.73m². 🔹 SGLT-2 Inhibitors: Recommended for kidney and cardiovascular protection, started at eGFR ≥20 mL/min/1.73m², continued until dialysis or kidney transplantation. 🔹 RAS Inhibitors (ACEi/ARB): First-line for hypertension and albuminuria, titrated to the maximum tolerated dose. 🔹 Statins: Initiated at moderate or high intensity to lower atherosclerotic cardiovascular disease (CVD) risk. 3️⃣ Advanced & Adjunctive Therapies: Precision Medicine 🔸 GLP-1 Receptor Agonists: If glycemic targets are not met. 🔸 Nonsteroidal MRA (Finerenone): Added if ACR ≥22.6 mg/mmol and eGFR ≥25 mL/min/1.73m² to reduce CKD progression. 🔸 Dihydropyridine Calcium Channel Blockers + Diuretics: For uncontrolled blood pressure. 🔸 Steroidal MRA: Considered in resistant hypertension with eGFR >45 mL/min/1.73m². 🔸 Antiplatelet Agents: Initiated in patients with established atherosclerotic CVD. 🔸 Lipid-Lowering Therapies (Ezetimibe, PCSK9i, Icosapent Ethyl): Used in patients with high atherosclerotic CVD risk despite statin therapy. 4️⃣ Ongoing Monitoring: Data-Driven Decision-Making Regular reassessment of: 📊 Glycemic control 📊 Albuminuria & blood pressure 📊 Cardiovascular risk & lipid profile This comprehensive patient-centered approach ensures proactive management, reduces CKD complications, and improves long-term outcomes. 💡 How do you approach diabetes & CKD management in your practice? Share your insights! #Diabetes #CKD #Pharmacotherapy #PrecisionMedicine #HealthcareInnovation

This is what Comprehensive Medication Management looks like in real life. Over the past several months, our team partnered with a medically complex adolescent managing Type 1 diabetes, anxiety, fatigue, and hormonal health concerns. Here is what we addressed: Medication Optimization • Identified low ondansetron dosing • Recommended adjusting insulin correction factors and basal settings after identifying overly aggressive corrections causing rapid glucose drops • Initiated vitamin D supplementation with PCP after reviewing low-normal levels • Recommended alternative SSRI with better pregnancy safety profile and guideline appropriate (e.g., sertraline, fluoxetine, escitalopram) over paroxetine. Safety + Risk Reduction • Developed a structured hypoglycemia correction plan using precise 15 g glucose tablet dosing • Coordinated pneumococcal vaccination for high-risk diabetes indication Access + Continuity • Ensured uninterrupted Omnipod 5 pod access • Coordinated with PCP regarding Depo-Provera administration to reduce travel burden to OBGYN 1 hour away. This was not one intervention. It was dozens. Not one visit. Months of longitudinal oversight. Medication management for medically complex children is never just about a prescription. It is about safety, monitoring, education, coordination, and preventing harm before it happens. This is the evolving role of the pediatric pharmacist. Clinical. Proactive. Embedded. And this is why Comprehensive Medication Management matters. Picture of one of our patients below ❤️

A medical diagnosis often answers one important question - what happened. But for patients and families, the real questions begin after that. 1. What does the future look like? 2. What kind of care will be needed months or even years from now? 3. How will medical needs, rehabilitation, and daily support be managed over time? This is where Life Care Planning becomes essential. Life care planning goes beyond identifying a condition. It creates a comprehensive roadmap for long-term care, helping address critical aspects such as: • Future medical treatments and ongoing healthcare needs • Rehabilitation therapies and recovery support • Assistive devices and specialized care services • Long-term care planning and lifestyle adjustments • Coordination between healthcare providers, families, and legal teams It bridges the gap between clinical insight and real-world care needs, helping patients and families make informed decisions with clarity and confidence. Because healthcare should never stop at diagnosis. True care means looking ahead, anticipating needs, and ensuring that every individual has a clear path toward the best possible quality of life. After all, a prognosis may describe a condition, but a plan empowers a life. #LifeCarePlanning #PatientAdvocacy #HealthcareStrategy #MedicalExpertise #FutureOfCare #MedLegal #HealthcareLeadership

CMS has continued to expand and reimburse Chronic Care Management (CCM) as a core primary care service, recognizing its role in improving outcomes and supporting patients between visits. It plays a critical role in keeping patients on track while reimbursing providers for non–face-to-face care management they’re providing on a monthly basis for services such as: Care coordination with other providers Medication management Reviewing labs, imaging, or consult notes Patient communication (phone, portal, etc.) Updating and managing the care plan At the same time, the Office of Inspector General has included CCM in its Work Plan recently, evaluating whether services billed meet Medicare requirements, especially around documentation, time, and care planning. Because CCM is a time-based, longitudinal service, it makes it particularly vulnerable to audit if documentation is not strong. Issus we see most often: • Time is documented, but not tied to clear clinical work. CMS requires that time spent “furnishing care management services” is supported by specific activities in the record. • Care plans are copied forward and not updated. • Patient consent is missing or unclear. • Limited documentation of coordination across providers and and follow-up on referrals. • Conditions lack specificity (severity, status, risk). Chronic conditions are listed but not described in a way that reflects complexity. What to check to avoid audit risk: • Tie documented time to specific clinical activities (care coordination, medication management, patient communication) • Ensure the care plan is current, patient-specific, actively managed, and updated to reflect the managememt. • Capture condition specificity and risk to reflect true patient complexity For a practical reference, the Centers for Medicare & Medicaid Services CCM guide is here: https://lnkd.in/gc9mqJqm If CCM is part of your strategy or something you’re interested in implementing, it’s worth assessing how well your documentation supports the care being delivered. If helpful to talk through this, reach out at Lindsay@chirokhealth.com

This is what Value Based, PT led model of care can look like. Structured, aligned and centered model of care. Take a listen to one of our episodes on Medbridge with Dana Prommel Strauss, or sign up to read our newsletters at Future Proof PT. We have the resources, ability and need for focused and structured care delivery systems. “Development of a Comprehensive, Nonsurgical Joint Health Program for Osteoarthritis” (Malay et al., 2020) Why the Program Was Needed 🦴 OA care in the U.S. is fragmented and inconsistent, often emphasizing procedures over conservative care. “Existing OA care models… fail to comprehensively evaluate or address the many biological, psychological, social, and behavioral factors…” 💸 Fee‑for‑service models undervalue behavioral, lifestyle, and coordinated care. 📈 Value‑based payment models are accelerating the need for scalable, conservative OA programs. What the Joint Health Program (JHP) Is 🧑⚕️ Physical therapist–led model where PTs serve as Primary OA Providers (POPs). 🧠 Biopsychosocial + behavior‑change framework guides all care. 🧩 Multidisciplinary network: PTs coordinate with dietitians, behavioral health, and orthopedic surgeons. 🎯 Focus on self‑management, shared decision-making, long-term follow-up, and multi‑modal interaction. How the Program Works 📝 Comprehensive intake: pain, disability, physical activity, nutrition, sleep, psychological distress, goals. 🧭 Stratified care pathways: Low‑touch: fewer visits, early self‑management. High‑touch: more visits + referrals (nutrition, behavioral health, sleep). 🔄 Longitudinal engagement: remote follow-ups at 1, 3, 6, and 12 months. 📡 Multi‑channel communication: in‑clinic, phone, email, EHR portal. Training & Role of the Primary OA Provider 🎓 POPs receive specialized training in: Cognitive‑behavioral strategies Pain education Sleep health Nutrition & weight management OA guidelines 🧠 POPs deliver conservative care and coordinate referrals. Pilot Outcomes 👍 Feasibility & acceptability demonstrated across patients, PTs, and referring clinicians. “Participant experience scores suggest they would be very likely… to recommend this program.” 📈 Rapid growth in referrals and provider engagement. 🧍♂️ PTs maintained productivity despite increased non‑billable coordination time. 📉 Early improvements in pain, function, and psychological distress (descriptive, not inferential). 🏥 Health system leadership endorsed expansion within 3 months. Why This Matters 🧭 JHP is a blueprint for value‑based, PT‑led chronic care models in OA and beyond. 🔍 It addresses the gaps in traditional OA care by integrating behavioral, psychological, and lifestyle interventions. 🚀 Sets the stage for future research on predictors of response and comparative effectiveness.